
Tandem Diabetes Care TNDM
$ 19.18
-2.54%
Annual report 2025
added 02-19-2026
Tandem Diabetes Care Interest Expense 2011-2026 | TNDM
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense Tandem Diabetes Care
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -13 M | 7.26 M | 13 M | -4 K | -6.75 M | -28.3 M | -7.88 M | -77.9 M | -10.1 M | -5.41 M | -3.4 M | -3.79 M | -13.7 M | 33 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13 M | -77.9 M | -10.7 M |
Quarterly Interest Expense Tandem Diabetes Care
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.28 M | -5.91 M | -1.21 M | - | 3.48 M | 1.03 M | 2.15 M | - | 816 K | 4.18 M | 4.23 M | - | 144 K | -711 K | -1.1 M | - | -1.87 M | -1.36 M | -1.92 M | - | -8.36 M | -17.1 M | -1.2 M | - | 3.18 M | 353 K | -12 M | - | -18.5 M | -45.4 M | -17.2 M | - | -2.87 M | -2.83 M | -2.57 M | - | -1.4 M | -1.27 M | -1.25 M | - | -882 K | -862 K | -798 K | - | -893 K | -879 K | -1.12 M | - | -934 K | -1.62 M | -4 M | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.23 M | -45.4 M | -3.61 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Align Technology
ALGN
|
7.68 M | $ 173.14 | -0.8 % | $ 13 B | ||
|
Bio-Rad Laboratories
BIO
|
48.9 M | $ 279.25 | 0.63 % | $ 7.88 B | ||
|
Alphatec Holdings
ATEC
|
45.9 M | $ 10.9 | -1.54 % | $ 1.64 B | ||
|
Acutus Medical
AFIB
|
5.66 M | - | -26.83 % | $ 2.62 M | ||
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 12.17 | -0.41 % | $ 1.64 B | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.3 | -1.79 % | $ 124 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
-38.2 M | $ 37.59 | -1.03 % | $ 5.6 K | ||
|
Boston Scientific Corporation
BSX
|
349 M | $ 61.79 | 0.83 % | $ 91.5 B | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 1.89 | - | $ 1.15 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 8.68 | -3.12 % | $ 246 M | ||
|
Electromed
ELMD
|
78 K | $ 24.12 | -1.19 % | $ 204 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.97 | 0.19 % | $ 375 M | ||
|
Inogen
INGN
|
2.44 M | $ 6.33 | -4.95 % | $ 168 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
LivaNova PLC
LIVN
|
664 K | $ 62.78 | -0.93 % | $ 3.42 B | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
LENSAR
LNSR
|
636 K | $ 5.7 | 4.4 % | $ 68.2 M | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 90.42 | -1.07 % | $ 12.2 B | ||
|
Butterfly Network
BFLY
|
-13 K | $ 4.11 | -0.96 % | $ 870 M | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.04 | 1.62 % | $ 360 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Myomo
MYO
|
-668 K | $ 0.69 | -1.43 % | $ 28.9 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 54.02 | -4.71 % | $ 1.59 B | ||
|
CONMED Corporation
CNMD
|
31.1 M | $ 36.74 | -0.51 % | $ 1.14 B | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 85.11 | -1.8 % | $ 2.96 B | ||
|
FONAR Corporation
FONR
|
347 K | $ 18.68 | 0.38 % | $ 122 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 77.87 | -1.62 % | $ 45.5 B |